Screening when where why
•
2 likes•285 views
Dr. Kawita Bapat is an OBGYN in Indore, India. She has extensive experience and qualifications in gynecology. Breast cancer rates are rising in India due to changes in lifestyle factors such as diet, reproduction patterns, and economic development. Currently, the breast cancer incidence rate in India is 19.1 per 100,000 people annually, which is lower than developed countries but peaks at a younger age. Many cases present at late stages with limited treatment options. Screening and awareness need to be improved to enhance early detection and survival rates.
More Related Content
What's hot
What's hot (20)
Similar to Screening when where why
Similar to Screening when where why (20)
More from Kawita Bapat
More from Kawita Bapat (20)
Recently uploaded
Recently uploaded (20)
Screening when where why
- 1. Screening When where why Dr. Kawita Bapat
- 2. Dr. Kawita Bapat • MS FICOG • Director Of One Centre For Gynecological Excellence • Senior Practicing Obgyn At Indore • One Day Hysterectomy Specialist • FOGSI Affiliated Colposcopy Center • Vice President (Elect) FOGSI,2021 • President Indore Menopause Society • Vice President AMPOG • President MP Chapter Of Vaginal Surgeons • Secretory MP IAGE • Executive Member ISAR • Executive Member IAGE • Chairperson Breast Committee FOGSI 16-18 • Past President OBGYN Society INDORE • GOVRNING COUNCIL MEMBER ICOG • Past President LIONS Club INDORE • Award Winner Of Nayika Indore And Captain Of Industry • bapatkawita@gmail.Com • www.Onegynae.Com • Bapat Hospital Bapat Choraha Sukhlia Indore +919826055666
- 4. • Breast cancer is an increasing health problem in India. • The trend of rising incidence rates is likely to con9nue due to further changes in lifestyle factors such as: -‐ Childbearing -‐ Dietary habits -‐ Early Menarche -‐ Late Marriages -‐ Less BreasBeeding -‐ Economic evolu9on of country
- 5. JNCI: Journal of the Na1onal Cancer Ins1tute, Volume 100, Issue 18, 17 September 2008, Pages 1270–1271, hOps://doi.org/10.1093/jnci/djn303 • The current age-standardized rate is 19.1 per 100 000 per annum, but, in contrast to what is observed in developed countries, the incidence rate peaks below age 50. Stage distribution at presentation is less favorable than in developed countries, with 50%–70% of cases presenting for treatment being locally advanced , and the availability and level of facilities for treatment are variable ..
- 6. JNCI: Journal of the Na1onal Cancer Ins1tute, Volume 100, Issue 18, 17 September 2008, Pages 1270–1271, hOps://doi.org/10.1093/jnci/djn303 • Survival rates are consequently low , and there is a clear need to improve the availability and accessibility of facilities for diagnosis and treatment, as well as education and awareness .
- 7. Screening test should be • Easy To Use • Cost Effec9ve • Available • Accessible • Reproducible • Can Be Applied In The Field Set Up, • Good Sensi9vity And Specificity • Branded awareness
- 8. 8 Clinical and self breast examina?on Mammography Gene?c screening Ultrasound Magne?c resonance imaging Molecular breast imaging
- 10. USPSTF ACS ACOG Recommends against clinicians teaching women how to perform Breast self-‐ examina9on Recommends against clinicians teaching women how to perform Breast self examina9on Consider Breast self examina?on instruc?on for high-‐risk pa9ents. Breast self-‐awareness should be encouraged and can include Breast self-‐examina9on Recommenda?ons for Breast Cancer Screening
- 11. Benefits & Harms of BSE
- 12. Gene9c Screening • One or more rela9ves with breast cancer diagnosed before age 50 • Two or more rela9ves diagnosed with breast cancer at any age • One or more rela9ves with ovarian cancer • One or more rela9ves with male breast cancer • Two or more rela9ves with prostate cancer or pancrea9c cancertwo or more rela9ves with brca-‐associated cancers • A history of breast cancer at A young age in two or more blood rela9ves, such as your parents, siblings or children • A rela9ve with A known BRCA1 or BRCA2 muta9on
- 15. mammogram • Biennial screening mammography is recommended for women in the 50–74 years age group, but is available to all women aged over 40 years. • Imaging plays a major role in the diagnosis, treatment, and follow-‐up of breast cancer. • Findings that require further assessment will be detected both at screening and cura9ve mammography
- 16. Digital Mammogram vs. Tradi?onal X-‐Ray Mammogram Digital Mammogram Traditional X-Ray Mammogram
- 17. 17 Digital Mammogram MRI Digital Mammogram vs. MRI
- 18. USPTSF • Biennial screening mammography beginning at age 50.(B Recommend) • Evidence is insufficient for assessing the addi9onal benefits of screening mammography in women past age 74 • Annual screening mammography beginning at age 45 with an op9on to begin at age 40. Transi9on to biennial screening at age 55 with op9on to con9nue annual screening • Con9nue biennial screening mammography for as long as a woman is in good health and a life expectancy of has at least 10 years • Annual Screening Mammography beginning at age 40 • Women aged 75 years and older should consult with their physicians to decide whether or not to con9nue screening mammography Controversies in Mammography ACS ACOG
- 19. • Mammography Screening Increased detec9on of precancerous lesions / In-‐situ • 25% of newly diagnosed BC cases in screening is DCIS.(FEA, ADH) • Biological Significance and prac9cal M/M Big challenge and s9ll unclear • Trials/Individual studies No reduc9on to 30-‐45% modest decrease in BC when screened every 1-‐2 years Controversies in Mammography
- 20. Key methods • Three-‐dimensional (3D) Approaches To X‑ray Mammography (Digital Breast Tomosynthesis), • Contrast-‐enhanced Mammography • Quan9fiable Ultrasound Techniques (E. G., Shear Wave Elastography) • • Func9onal Magne9c Resonance Imaging (Mri; E. G., Contrast-‐enhanced MRI, Diffusion-‐weighted Imaging). • This Review Focuses On These Techniques And Their Poten9al Use In The Breast Clinic.
- 21. Breast imaging workflow. Boxes represent typical steps in the breast imaging workflow, logical steps are connected by arrows. Circles indicate where the new imaging tools discussed in this ar9cle can be of help. ARFI acous9c radia9on force impulse, DBT digital breast tomosynthesis, DWI diffusion-‐weighted imaging
- 22. Conclusion • Benefits of Screening • Screening for breast cancer means looking for signs of breast cancer in all women, even if they have no symptoms. • The goal of screening is to catch cancers early. • Early-‐stage cancers are easier to treat than later-‐stage cancers • chance of survival is higher. • Rou1ne screening for breast cancer lowers one’s risk of dying of breast cancer.
- 23. THANK YOU